openPR Logo
Press release

Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix

09-25-2024 08:18 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Neurological Biomarkers Market

Neurological Biomarkers Market

๐“๐ก๐ž ๐ซ๐ž๐œ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐›๐ฅ๐ข๐ฌ๐ก๐ž๐ ๐๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐”๐’๐ƒ ๐Ÿ–.๐Ÿ๐Ÿ— ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ‘.๐ŸŽ๐ŸŽ% ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.
๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐จ๐Ÿ๐Ÿ๐ž๐ซ ๐š๐ง ๐š๐›๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐จ๐Ÿ ๐”๐’๐ƒ ๐Ÿ๐Ÿ’.๐Ÿ–๐Ÿ‘ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

The need for neurological biomarkers has grown as a result of the growing existence of neurological illnesses involving conditions such as migraine, dementia, Alzheimer's disease, brain tumors, epilepsy, and others is confident of driving market augmentation. For instance, as per WHO, epilepsy causes roughly 13 million impairments calibrated life cycle and accounts for more than 0.5% of the global disease loads.

๐†๐ž๐ญ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market/request-for-sample

Lately, biomarkers have been increasingly embraced in clinical patterns and clinical attempts in the area of neurology. The tempo of detection has been speeding due to technological progressions with escalated accuracy and susceptibility of the instrument and assays and cross-fertilization from one area of neurology to another. The weapons of biomarkers in neurology are prone to continue growing as the potential to estimate precisely manifold biological dynamics and knowhow about the pathophysiology of neurological illnesses escalate. They are utilized for many causes, to steer clinical diagnosis, to approximate illness probability or prognosis, to gauge illness phase, and to observe advancement or answer to therapy.

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐
The market is portrayed by fierce contention, with entrenched players depending on progressive technology, elevated standard commodities, and a robust brand image to push revenue growth.

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ฐ๐ก๐ข๐œ๐ก ๐š๐ซ๐ž ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐๐จ๐ฆ๐ข๐ง๐š๐ญ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž:
โ€ข Abbott
โ€ข Alseres Pharmaceuticals, Inc.
โ€ข BANYAN BIOMARKERS, INC.
โ€ข Bio-Rad Laboratories, Inc.
โ€ข DiaGenic ASA
โ€ข Johnson & Johnson Services, Inc.
โ€ข Merck & Co., Inc.
โ€ข Myriad Genetics, Inc.
โ€ข Quanterix
โ€ข Thermo Fisher Scientific, Inc.

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/2965/0

๐Š๐ž๐ฒ ๐“๐š๐ค๐ž๐š๐ฐ๐š๐ฒ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ
โ€ข The primary factors propelling the market growth of neurological biomarkers are blood-based biomarkers, playing an important part in choosing relevant remedies and observing disease advancement.
โ€ข The neurological biomarkers market analysis is mainly based on type, application, end-use, and region.
โ€ข North America dominated the market.
โ€ข The market in Asia Pacific will increase as a result of the growth of clinical trials in surfacing nations such as China and India and a growing illness weight.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ
๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐ข๐ฆ๐š๐ซ๐ข๐ฅ๐ฒ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ญ๐ฒ๐ฉ๐ž, ๐š๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง, ๐ž๐ง๐-๐ฎ๐ฌ๐ž, ๐š๐ง๐ ๐ซ๐ž๐ ๐ข๐จ๐ง.
๐๐ฒ ๐“๐ฒ๐ฉ๐ž
โ€ข Metabolomic
โ€ข Genomic
โ€ข Imaging
โ€ข Proteomic
โ€ข Others

๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ€ข Autism Spectrum Disorder
โ€ข Parkinson's Disease
โ€ข Alzheimer's Disease
โ€ข Multiple Sclerosis
โ€ข Others

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž
โ€ข Independent clinical diagnostic centers
โ€ข Research Organizations and Others
โ€ข Hospital & Hospital Laboratories

๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง
โ€ข North America (U.S., Canada)
โ€ข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โ€ข Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
โ€ข Latin America (Brazil, Mexico, Argentina)
โ€ข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

๐“๐จ๐ฉ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
โ€ข Offers a thorough analysis of neurological biomarkers market covering all the major aspects.
โ€ข Provides an estimation of the current, historical, and projected market size in terms of volume and value.
โ€ข Includes a detailed market segmentation covering all the major segments and sub-segments.
โ€ข An examination of the top market trends and developments has been provided in the report.
โ€ข Assesses the strategies of key market players and their product offerings.
โ€ข The study analyzes the changing market dynamics and classifies new partners or clients in the target demographic.

๐‚๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž ๐ญ๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market

๐Š๐ž๐ฒ ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐€๐ง๐ฌ๐ฐ๐ž๐ซ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
โ€ข What is the current neurological biomarkers market size and forecast value?
โ€ข Who are the key players in the market?
โ€ข What are the opportunities and challenges market players might encounter?
โ€ข What are the key trends driving the market growth?
โ€ข At what CAGR is the market anticipated to grow?
โ€ข What is the estimated demand for different types of products/services in the market?

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
๐Ž๐ฑ๐ข๐๐š๐ญ๐ข๐ฏ๐ž ๐’๐ญ๐ซ๐ž๐ฌ๐ฌ ๐€๐ฌ๐ฌ๐š๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/oxidative-stress-assay-market

๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/regulatory-information-management-system-market

๐”.๐’. ๐ƒ๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/us-diabetes-devices-market

๐€๐ฅ๐ฅ๐ž๐ซ๐ ๐ฒ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/allergy-diagnostics-market

๐†๐ฅ๐ฎ๐œ๐จ๐ฌ๐ž ๐๐ข๐จ๐ฌ๐ž๐ง๐ฌ๐จ๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/glucose-biosensors-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
๐‹๐ข๐ค๐ก๐ข๐ฅ ๐†
8 The Green Ste 19824,
Dover, DE 19901,
United States
๐๐ก๐จ๐ง๐ž:+1-929 297-9727
๐„๐ฆ๐š๐ข๐ฅ: sales@polarismarketresearch.com
๐–๐ž๐›: https://www.polarismarketresearch.com
๐…๐จ๐ฅ๐ฅ๐จ๐ฐ ๐”๐ฌ: LinkedIn | Twitter

๐€๐›๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก & ๐‚๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐ˆ๐ง๐œ:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix here

News-ID: 3666777 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

IoT Medical Devices Market 2024 Top Manufacturers are: Abbott Laboratories, AliveCor, Inc., Baxter International Inc.
IoT Medical Devices Market 2024 Top Manufacturers are: Abbott Laboratories, Aliv โ€ฆ
๐ˆ๐จ๐“ ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ-๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐’๐ข๐ณ๐ž ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ, ๐š๐ง๐ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ˆ๐จ๐“ ๐ฆ๐ž๐๐ข๐œ๐š๐ฅ ๐๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฐ๐จ๐ซ๐ญ๐ก ๐”๐’๐ƒ ๐Ÿ’๐Ÿ‘.๐Ÿ‘๐Ÿ– ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ“๐Ÿ’๐Ÿ.๐Ÿ๐Ÿ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ‘๐Ÿ.๐Ÿ’๐ŸŽ% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž: This comprehensive study provides an accurate overview of the worldwide IoT medical devices market. Comprehensive analyses of sales volume, price, revenue, market share, andโ€ฆ
Intelligent Power Module Market is Predicted to Expand to 7.71 Billion with a CAGR of 11.0% From 2024 to 2032
Intelligent Power Module Market is Predicted to Expand to 7.71 Billion with a CA โ€ฆ
An integrated power module, or IPM, is a module containing different power electronics components like power switches, gate drivers, and protection circuits. IPMs are designed to offer effective supervision and management for high-power applications by including functions like overcurrent protection, thermal regulation, and advanced control algorithms, allowing them to be utilized in motor controls, renewable energy setups, and industrial automation. IPMs are small, dependable, and provide effective power management, makingโ€ฆ
Cybersecurity Insurance Market to Witness Impressive Expansion of USD 48.83 Billion with CAGR Of 19.29% during the Forecast Period 2030
Cybersecurity Insurance Market to Witness Impressive Expansion of USD 48.83 Bill โ€ฆ
Cybersecurity Insurance Market Insights, Size Revenue, Outlook, Overview, and Analysis. The global cybersecurity insurance market was estimated to be worth USD 10.13 billion in 2021 and is predicted to expand to USD 48.83 billion by 2030, with a CAGR of 19.29% from 2022 to 2030. ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž: This comprehensive study provides an accurate overview of the worldwide cybersecurity insurance market. Comprehensive analyses of sales volume, price, revenue, market share, and importantโ€ฆ
With 17.7% CAGR, Cold Chain Monitoring Market Size Value To Reach USD 25,963.49 Million By 2032
With 17.7% CAGR, Cold Chain Monitoring Market Size Value To Reach USD 25,963.49 โ€ฆ
The cold chain monitoring market size was valued at USD 5,284.14 million in 2022. The market is projected to grow to USD 25,963.49 million by 2032, exhibiting a compound annual growth rate (CAGR) of 17.7% from 2023 to 2032. ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง: Cold chain monitoring is an intricate supply system that makes use of IoT technology to supervise perishable items such as vaccines, chemicals, and pharmaceutical products that need precise temperature regulation.โ€ฆ

All 5 Releases


More Releases for Neurological

Neurological Disorder Drugs Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Neurological Disorder Drugs Market is projected to grow at a CAGR value of 5.6% from 2022 to 2027. The rising cases of neurodegenerative diseases such as dementia and Alzheimer's disease, a susceptible aging population, and an increase in research and development projects by numerous pharmaceutical companies are factors fueling market growth during the forecast period. Pfizer Inc,โ€ฆ
Neurological Biomarkers Market 2021 | Detailed Report
ReportsnReports publishes the report titled Neurological Biomarkers that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,โ€ฆ
Global Neurological Biomarkers Market - Forecast to 2026
The findings reviewed by GME stated that the Global Neurological Biomarkers Market would grow at a CAGR value of 10.2 percent from 2021 to 2026. Today, with advancing technology and neurological applications, the awareness about the effectiveness of biomarker signature in diagnosing diseases or disorders is also increasing. Besides the beneficial features attributed to the neurological biomarkers, the annual exponential increase in the rate of neurological diseases is also acceleratingโ€ฆ
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!! We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming โ€œ7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)โ€ scheduled to be held on September 20-21, 2018 in Rome, Italy. The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &โ€ฆ
Neurological Biomarkers Market Competition Insights 2025
Global Neurological Biomarkers Market: Overview This report on the global neurological biomarkers market is a comprehensive market intelligence study that brings forth the lucrativeness of the said market. Beginning with an executive summary that comprise a snapshot of how the demand for neurological biomarkers has evolved over the recent past and where is it headed to in the future, the report delves into the analysis of various market dynamics, such asโ€ฆ
Neurological Biomarkers Market: Pipeline Overview 2017 - 2025
Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience,โ€ฆ